Abstract
BackgroundTargeted thorium-227 conjugates (TTCs) are an emerging class of targeted alpha therapies (TATs). Their unique mode of action (MoA) is the induction of difficult-to-repair clustered DNA double-strand breaks. However, thus...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have